Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.
About 0.08% of WINT shares are held by financial institutions. TOWER RESEARCH CAPITAL LLC (TRC) is the top corporate investor, holding 2.21K shares valued at $1.14K. A 20.32% stake in Windtree Therapeutics, Inc. is owned by the company. JANE STREET GROUP, LLC owns 14.6K shares valued at $7.53K, which translates its holding of 134.12% of the stake in the company.
Among the WINT insiders holding of 0% of the stake in company, CENTER LABORATORIES, INC., 10 percent owner, holds the largest shares of 1.24M. LEE'S PHARMACEUTICAL HOLDINGS LTD, 10 percent owner, is the second largest WINT insider with ownership of 827.82K shares. LPH II INVESTMENTS LTD, 10 percent owner, stands third with possession of 827.82K shares of that stake.
| Insiders | Designation | Shares Held |
|---|
| CENTER LABORATORIES, INC. | 10 percent owner | 1.24M |
| LEE'S PHARMACEUTICAL HOLDINGS LTD | 10 percent owner | 827.82K |
| LPH II INVESTMENTS LTD | 10 percent owner | 827.82K |
| HUANG JAMES | director | 291.28K |
| SIMONSON STEVEN | SVP, Chief Medical Officer | 83.6K |
| HAMILL JOHN P. | SVP & CFO | 72.8K |
| FRASER CRAIG | President and CEO | 8.64K |
| PEACOCK BRUCE | director | 3.5K |
| SCHREIBER BRIAN D | director | 2.07K |
| GEFFKEN DANIEL E. | director | 2.07K |
| LEONE JOHN R | director | 2.07K |
| JOSEPH MAHADY M | director | 2.07K |
| CURTIS ERIC | SVP & COO | 1.29K |
| TEMPLETON MARY B ESQ | SVP, Gen Counsel & Corp Sec | 1.1K |
| TATTORY JOHN A | SVP & CFO | 449 |
| BIOENGINE CAPITAL INC. | 10 percent owner | 0 |
